Eagle Asset Management’s Biolase, Inc. BIOL Stock Holding History

Eagle Asset Management’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-90	Closed	-$1.01M	–	673
2015 Q3	$1.01M	Hold	90	–	–	0.01%	603
2015 Q2	$1.95M	Hold	90	–	–	0.01%	560
2015 Q1	$2.27M	Buy	90 +2	+2%	+$56.7K	0.01%	524
2014 Q4	$2.88M	Buy	88 +64	+267%	+$2M	0.02%	498
2014 Q3	$750K	Hold	24	–	–	﹤0.01%	613
2014 Q2	$663K	Buy	24 +1	+4%	+$25.5K	﹤0.01%	620
2014 Q1	$681K	Sell	23 -25	-52%	-$872K	﹤0.01%	631
2013 Q4	$1.69M	Sell	48 -5	-9%	-$119K	0.01%	594
2013 Q3	$1.32M	Sell	53 -216	-80%	-$6.96M	0.01%	662
2013 Q2	$11.8M	Buy	+269	New	+$15M	0.08%	318

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

PCMI

Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Eagle Asset Management's BIOL Position: Q4 2015 in Review

Eagle Asset Management sold out of Biolase, Inc. (BIOL) in Q4 2015, closing a stake of 90 shares — an estimated $1.01M sold.

Eagle Asset Management first reported a position in BIOL in Q2 2013 and held it in 10 quarters. The position peaked at $11.8M in Q2 2013. 30 funds tracked by Wall St. Rank hold BIOL as of Q4 2015.

Eagle Asset Management reported no remaining Biolase, Inc. position as of Q4 2015 after selling out during the quarter.
Eagle Asset Management sold 90 Biolase, Inc. shares in Q4 2015, an estimated $1.01M.
Eagle Asset Management first reported a position in Biolase, Inc. in Q2 2013 and held it in 10 quarters.
Eagle Asset Management's Biolase, Inc. position peaked at $11.8M in Q2 2013.
30 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2015.

Based on Eagle Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.